- $103.02bn
- $125.33bn
- $195.27bn
- 79
- 69
- 95
- 95
Annual cashflow statement for Cigna, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 5,120 | 8,489 | 5,415 | 6,746 | 5,372 |
| Depreciation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | -175 | -4,153 | -55 | -1,167 | 1,577 |
| Unusual Items | |||||
| Changes in Working Capital | 1,202 | 3,598 | -872 | 620 | 3,488 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Net Change in Other Assets & Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 9,485 | 10,350 | 7,191 | 8,656 | 11,813 |
| Capital Expenditures | -1,050 | -1,094 | -1,154 | -1,295 | -1,573 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 316 | 4,070 | -2,457 | 4,393 | -3,601 |
| Acquisition of Business | |||||
| Sale of Business | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -734 | 2,976 | -3,611 | 3,098 | -5,174 |
| Financing Cash Flow Items | -249 | -131 | 24 | -79 | -469 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -7,187 | -8,533 | -8,212 | -11,240 | -4,294 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 1,556 | 4,834 | -4,697 | 428 | 2,361 |